- Home
- LEXX vs GROV Comparison
LEXX vs GROV Comparison
Compare LEXX & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEXX
- GROV
- Stock Information
- Founded
- LEXX 2004
- GROV 2016
- Country
- LEXX Canada
- GROV United States
- Employees
- LEXX 7
- GROV N/A
- Industry
- LEXX Biotechnology: Pharmaceutical Preparations
- GROV Package Goods/Cosmetics
- Sector
- LEXX Health Care
- GROV Consumer Discretionary
- Exchange
- LEXX Nasdaq
- GROV Nasdaq
- Market Cap
- LEXX 38.9M
- GROV 59.0M
- IPO Year
- LEXX N/A
- GROV N/A
- Fundamental
- Price
- LEXX $2.23
- GROV $1.40
- Analyst Decision
- LEXX Strong Buy
- GROV Buy
- Analyst Count
- LEXX 2
- GROV 1
- Target Price
- LEXX $11.00
- GROV $2.00
- AVG Volume (30 Days)
- LEXX 202.4K
- GROV 149.8K
- Earning Date
- LEXX 01-10-2025
- GROV 11-12-2024
- Dividend Yield
- LEXX N/A
- GROV N/A
- EPS Growth
- LEXX N/A
- GROV N/A
- EPS
- LEXX N/A
- GROV N/A
- Revenue
- LEXX $464,278.00
- GROV $213,781,000.00
- Revenue This Year
- LEXX $20.39
- GROV N/A
- Revenue Next Year
- LEXX $113.25
- GROV $0.84
- P/E Ratio
- LEXX N/A
- GROV N/A
- Revenue Growth
- LEXX 105.24
- GROV N/A
- 52 Week Low
- LEXX $1.20
- GROV $1.19
- 52 Week High
- LEXX $6.85
- GROV $2.44
- Technical
- Relative Strength Index (RSI)
- LEXX 47.23
- GROV 47.22
- Support Level
- LEXX $2.00
- GROV $1.30
- Resistance Level
- LEXX $2.54
- GROV $1.56
- Average True Range (ATR)
- LEXX 0.24
- GROV 0.08
- MACD
- LEXX -0.00
- GROV -0.02
- Stochastic Oscillator
- LEXX 27.06
- GROV 37.88
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products.